[HTML][HTML] Salbutamol in the management of asthma: A review

L Marques, N Vale - International Journal of Molecular Sciences, 2022 - mdpi.com
Asthma is a common inflammatory disease of the lungs. The prevalence of asthma is
increasing worldwide, and the tendency indicates that the number of asthma sufferers will …

Status asthmaticus in children: a review

HA Werner - Chest, 2001 - Elsevier
About 10% of American children have asthma, and its prevalence, morbidity, and mortality
have been increasing. Asthma is an inflammatory disease with edema, bronchial …

Therapeutic responses in asthma and COPD: bronchodilators

JF Donohue - Chest, 2004 - Elsevier
The presence of acute reversibility to bronchodilators does not distinguish asthma from
COPD. Patients with either condition can benefit from bronchodilators, and should be given …

Ultrasensitive Magnetic Assisted Lateral Flow Immunoassay Based on Chiral Monoclonal Antibody against R-(−)-Salbutamol of Broad-Specificity for 38 β-Agonists …

J Liang, Z Liu, H Xie, Y Fang, Q Quan… - Journal of Agricultural …, 2022 - ACS Publications
Screening for ″zero tolerance ″β-agonists requires broad-specificity and sensitivity
methods. Herein, R-(−)-salbutamol (SAL) is chirally separated and designed as a hapten …

Comparison of racemic albuterol and levalbuterol for treatment of acute asthma

JC Carl, TR Myers, HL Kirchner, CM Kercsmar - The Journal of pediatrics, 2003 - Elsevier
OBJECTIVE: To determine whether levalbuterol resulted in fewer hospital admissions than
racemic albuterol when used for treatment of acute asthma. STUDY DESIGN: A randomized …

Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol

H Milgrom, DP Skoner, G Bensch, KT Kim… - Journal of allergy and …, 2001 - Elsevier
Background: Racemic albuterol (RAC) is an equal mixture of (R)-albuterol and (S)-albuterol.
Only the (R)-isomer, levalbuterol (LEV), is therapeutically active. Lower doses of LEV …

The pharmacokinetics of levosalbutamol: what are the clinical implications?

DW Boulton, JP Fawcett - Clinical pharmacokinetics, 2001 - Springer
Salbutamol (albuterol) is a β 2-adrenoceptor agonist used as a bronchodilator for the
treatment of asthma and as a uterine relaxant for the suspension of premature labour …

[HTML][HTML] Comparison of salbutamol delivery efficiency for jet versus mesh nebulizer using mice

KH Chang, SH Moon, JY Oh, YS Yoon, N Gu, CY Lim… - Pharmaceutics, 2019 - mdpi.com
Recent reports using a breathing simulator system have suggested that mesh nebulizers
provide more effective medication delivery than jet nebulizers. In this study, the …

Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma

F Qureshi, A Zaritsky, C Welch, T Meadows… - Annals of emergency …, 2005 - Elsevier
STUDY OBJECTIVE: An efficacy treatment study is conducted comparing levalbuterol to
racemic albuterol for acute pediatric asthma in the emergency department (ED). METHODS …

The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients

J Lötvall, M Palmqvist, P Arvidsson, A Maloney… - Journal of allergy and …, 2001 - Elsevier
Background: It has been suggested that R-albuterol produces bronchodilation that is
comparable with that of racemic albuterol (RS-albuterol) on a 4: 1 dose-for-dose basis but …